2024 Q2 Form 10-Q Financial Statement

#000095017024090222 Filed on August 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4
Revenue $3.502M $90.20M
YoY Change -95.47% 26.56%
Cost Of Revenue $18.68M $21.62M
YoY Change 4.16% 26.22%
Gross Profit $57.83M $68.58M
YoY Change -2.64% 26.66%
Gross Profit Margin 1651.46% 76.03%
Selling, General & Admin $36.99M $57.22M
YoY Change -13.33% 52.1%
% of Gross Profit 63.96% 83.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.590M $4.182M
YoY Change -62.92% 2.25%
% of Gross Profit 2.75% 6.1%
Operating Expenses $36.99M $61.40M
YoY Change -21.24% 47.21%
Operating Profit -$2.408M $7.176M
YoY Change -119.36% -42.28%
Interest Expense $11.26M -$11.07M
YoY Change -239.0% 229.34%
% of Operating Profit -154.25%
Other Income/Expense, Net $253.0K -$96.00K
YoY Change -136.25% -81.64%
Pretax Income -$13.53M -$8.216M
YoY Change -148.92% -2691.8%
Income Tax $132.0K $859.0K
% Of Pretax Income
Net Earnings -$9.102M $3.068M
YoY Change -119.17% -110.57%
Net Earnings / Revenue -259.91% 3.4%
Basic Earnings Per Share -$0.29
Diluted Earnings Per Share -$0.29 $0.08
COMMON SHARES
Basic Shares Outstanding 31.81M
Diluted Shares Outstanding 31.81M

Balance Sheet

Concept 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.00M $37.09M
YoY Change -54.72% 15.96%
Cash & Equivalents $26.02M $37.09M
Short-Term Investments
Other Short-Term Assets $2.313M $12.48M
YoY Change -89.94% -21.07%
Inventory $13.27M $14.72M
Prepaid Expenses $3.282M $3.107M
Receivables $29.77M $32.75M
Other Receivables $2.999M $203.0K
Total Short-Term Assets $85.72M $97.25M
YoY Change -11.25% 13.43%
LONG-TERM ASSETS
Property, Plant & Equipment $18.55M $19.50M
YoY Change -82.63% 5.28%
Goodwill $163.0M $171.6M
YoY Change -4.41% 3.56%
Intangibles $120.2M $120.1M
YoY Change -3.86% -12.41%
Long-Term Investments
YoY Change
Other Assets $1.159M $1.442M
YoY Change -97.45% 81.38%
Total Long-Term Assets $389.5M $431.5M
YoY Change -13.16% 8.69%
TOTAL ASSETS
Total Short-Term Assets $85.72M $97.25M
Total Long-Term Assets $389.5M $431.5M
Total Assets $475.2M $528.7M
YoY Change -12.82% 9.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.69M $19.12M
YoY Change -15.3% 18.13%
Accrued Expenses $14.41M $14.09M
YoY Change -51.73% 14.58%
Deferred Revenue $29.34M $34.67M
YoY Change -15.08% 8.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.147M $4.760M
YoY Change 20.82% 56.84%
Total Short-Term Liabilities $91.83M $92.31M
YoY Change -8.58% 26.84%
LONG-TERM LIABILITIES
Long-Term Debt $318.5M $319.3M
YoY Change 23.68% 139.98%
Other Long-Term Liabilities $4.831M $9.152M
YoY Change -97.7% 6.01%
Total Long-Term Liabilities $323.3M $328.4M
YoY Change -30.84% 131.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $91.83M $92.31M
Total Long-Term Liabilities $323.3M $328.4M
Total Liabilities $576.0M $616.8M
YoY Change 10.37% 61.19%
SHAREHOLDERS EQUITY
Retained Earnings -$642.1M -$630.1M
YoY Change 3.43% -1.83%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.697M $1.697M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$151.9M -$125.2M
YoY Change
Total Liabilities & Shareholders Equity $475.2M $528.7M
YoY Change -12.82% 9.53%

Cashflow Statement

Concept 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$9.102M $3.068M
YoY Change -119.17% -110.57%
Depreciation, Depletion And Amortization $1.590M $4.182M
YoY Change -62.92% 2.25%
Cash From Operating Activities $3.001M -$2.772M
YoY Change -84.38% -119.52%
INVESTING ACTIVITIES
Capital Expenditures $2.636M $637.0K
YoY Change -21.5% -82.46%
Acquisitions
YoY Change
Other Investing Activities $79.00K -$3.357M
YoY Change -39.23% -666.1%
Cash From Investing Activities -$2.557M -$3.994M
YoY Change -20.79% 31.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.645M -8.020M
YoY Change -58.16% 71.18%
NET CHANGE
Cash From Operating Activities 3.001M -2.772M
Cash From Investing Activities -2.557M -3.994M
Cash From Financing Activities -1.645M -8.020M
Net Change In Cash -1.201M -14.79M
YoY Change -109.96% -328.36%
FREE CASH FLOW
Cash From Operating Activities $3.001M -$2.772M
Capital Expenditures $2.636M $637.0K
Free Cash Flow $365.0K -$3.409M
YoY Change -97.7% -132.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001802156
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0D
CY2024Q2 us-gaap Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#AssetImpairmentCharges
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
us-gaap Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration
RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherExpenses
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40638
dei Entity Registrant Name
EntityRegistrantName
Xponential Fitness, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4395129
dei Entity Address Address Line1
EntityAddressAddressLine1
17877 Von Karman Ave.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
346-3000
dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
XPOF
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26017000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37094000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29771000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32751000
CY2024Q2 us-gaap Inventory Net
InventoryNet
13273000
CY2023Q4 us-gaap Inventory Net
InventoryNet
14724000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8242000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5856000
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
8066000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
6620000
CY2024Q2 xpof Notes Receivable From Franchisees Net Current
NotesReceivableFromFranchiseesNetCurrent
352000
CY2023Q4 xpof Notes Receivable From Franchisees Net Current
NotesReceivableFromFranchiseesNetCurrent
203000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
85721000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
97248000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18553000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19502000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43387000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71413000
CY2024Q2 us-gaap Goodwill
Goodwill
163036000
CY2023Q4 us-gaap Goodwill
Goodwill
171601000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120232000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120149000
CY2024Q2 us-gaap Deferred Costs
DeferredCosts
43043000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
46541000
CY2024Q2 xpof Notes Receivable From Franchisees Noncurrent
NotesReceivableFromFranchiseesNoncurrent
108000
CY2023Q4 xpof Notes Receivable From Franchisees Noncurrent
NotesReceivableFromFranchiseesNoncurrent
802000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1159000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1442000
CY2024Q2 us-gaap Assets
Assets
475239000
CY2023Q4 us-gaap Assets
Assets
528698000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
22694000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19119000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14411000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14088000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
29343000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
34674000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5147000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4760000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20235000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
19666000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
91830000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
92307000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111232000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
117305000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11600000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
8666000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
318454000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
319261000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38047000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70141000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4831000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9152000
CY2024Q2 us-gaap Liabilities
Liabilities
575994000
CY2023Q4 us-gaap Liabilities
Liabilities
616832000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
507986000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
521998000
CY2024Q2 xpof Notes Receivable By Shareholder Or Owner To Limited Liability Company Llc Or Incorporated Inc
NotesReceivableByShareholderOrOwnerToLimitedLiabilityCompanyLlcOrIncorporatedInc
16135000
CY2023Q4 xpof Notes Receivable By Shareholder Or Owner To Limited Liability Company Llc Or Incorporated Inc
NotesReceivableByShareholderOrOwnerToLimitedLiabilityCompanyLlcOrIncorporatedInc
15426000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-642096000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-630127000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
75000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
75000
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1697000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1697000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-151937000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-125247000
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-71721000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-77547000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-223658000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-202794000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
475239000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
528698000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76517000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77340000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156038000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
148030000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36989000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37210000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74144000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72095000
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
12089000
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
7238000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
12089000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
7238000
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4517000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4288000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8953000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8485000
CY2024Q2 us-gaap Marketing Expense
MarketingExpense
7847000
CY2023Q2 us-gaap Marketing Expense
MarketingExpense
5466000
us-gaap Marketing Expense
MarketingExpense
14362000
us-gaap Marketing Expense
MarketingExpense
10472000
CY2024Q2 xpof Business Acquisition And Transaction Expenses Income
BusinessAcquisitionAndTransactionExpensesIncome
-1217000
CY2023Q2 xpof Business Acquisition And Transaction Expenses Income
BusinessAcquisitionAndTransactionExpensesIncome
-31252000
xpof Business Acquisition And Transaction Expenses Income
BusinessAcquisitionAndTransactionExpensesIncome
3298000
xpof Business Acquisition And Transaction Expenses Income
BusinessAcquisitionAndTransactionExpensesIncome
-15510000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
78925000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
40887000
us-gaap Costs And Expenses
CostsAndExpenses
151058000
us-gaap Costs And Expenses
CostsAndExpenses
118784000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2408000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36453000
us-gaap Operating Income Loss
OperatingIncomeLoss
4980000
us-gaap Operating Income Loss
OperatingIncomeLoss
29246000
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
387000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
529000
us-gaap Investment Income Interest
InvestmentIncomeInterest
750000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1165000
CY2024Q2 us-gaap Interest Expense
InterestExpense
11256000
CY2023Q2 us-gaap Interest Expense
InterestExpense
8627000
us-gaap Interest Expense
InterestExpense
22801000
us-gaap Interest Expense
InterestExpense
16604000
CY2024Q2 us-gaap Other Expenses
OtherExpenses
253000
CY2023Q2 us-gaap Other Expenses
OtherExpenses
698000
us-gaap Other Expenses
OtherExpenses
862000
us-gaap Other Expenses
OtherExpenses
1252000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11122000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8796000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22913000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16691000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13530000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27657000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17933000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12555000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
132000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-13662000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
27524000
us-gaap Profit Loss
ProfitLoss
-18018000
us-gaap Profit Loss
ProfitLoss
12545000
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4560000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9145000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6049000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4149000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-9102000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
18379000
us-gaap Net Income Loss
NetIncomeLoss
-11969000
us-gaap Net Income Loss
NetIncomeLoss
8396000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31806000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33045000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31465000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31906000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31806000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41593000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31465000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50059000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-202794000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3253000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-4356000
CY2024Q1 xpof Loan To Shareholder And Accumulated Interest
LoanToShareholderAndAccumulatedInterest
-349000
CY2024Q1 us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
36000
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1863000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
8106000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-214251000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4885000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-13662000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
74000
CY2024Q2 xpof Loan To Shareholder And Accumulated Interest
LoanToShareholderAndAccumulatedInterest
-360000
CY2024Q2 us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
206000
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2150000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
-2012000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-223658000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-208062000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5612000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-14979000
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2069000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
62660000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-7935000
CY2023Q1 xpof Deemed Contributions From Redemption Of Preferred Stock
DeemedContributionsFromRedemptionOfPreferredStock
12679000
CY2023Q1 xpof Liability Classified Restricted Stock Unit Vested
LiabilityClassifiedRestrictedStockUnitVested
2250000
CY2023Q1 xpof Loan To Shareholder And Accumulated Interest
LoanToShareholderAndAccumulatedInterest
-3587000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-278751000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5611000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
27524000
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1857000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
-45551000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-176000
CY2023Q2 xpof Loan To Shareholder And Accumulated Interest
LoanToShareholderAndAccumulatedInterest
-1683000
CY2023Q2 xpof Receivable From Shareholder Arising From The Rumble Studios Acquisition
ReceivableFromShareholderArisingFromTheRumbleStudiosAcquisition
1450000
CY2023Q2 xpof Consideration Related To The Rumble Studios Acquisition
ConsiderationRelatedToTheRumbleStudiosAcquisition
1000
CY2023Q2 xpof Payment Received From Shareholders
PaymentReceivedFromShareholders
1290000
CY2023Q2 us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
532000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-204472000
us-gaap Profit Loss
ProfitLoss
-18018000
us-gaap Profit Loss
ProfitLoss
12545000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8953000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8485000
xpof Amortization And Write Off Of Debt Issuance Cost
AmortizationAndWriteOffOfDebtIssuanceCost
124000
xpof Amortization And Write Off Of Debt Issuance Cost
AmortizationAndWriteOffOfDebtIssuanceCost
296000
xpof Amortization Of Discount On Long Term Debt
AmortizationOfDiscountOnLongTermDebt
2201000
xpof Amortization Of Discount On Long Term Debt
AmortizationOfDiscountOnLongTermDebt
1218000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-2770000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
15510000
xpof Non Cash Lease Expense
NonCashLeaseExpense
3937000
xpof Non Cash Lease Expense
NonCashLeaseExpense
3347000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1467000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
897000
us-gaap Share Based Compensation
ShareBasedCompensation
8138000
us-gaap Share Based Compensation
ShareBasedCompensation
12111000
xpof Non Cash Interest
NonCashInterest
-649000
xpof Non Cash Interest
NonCashInterest
-856000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6660000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-133000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
12089000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
7238000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1715000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2022000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1451000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
983000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2386000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5280000
xpof Increase Decrease In Operating Lease Right Of Use Asset And Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilities
-2699000
xpof Increase Decrease In Operating Lease Right Of Use Asset And Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilities
-2636000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-2051000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1192000
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
-2000
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
-2000
xpof Increase Decrease In Notes Payable
IncreaseDecreaseInNotesPayable
3419000
xpof Increase Decrease In Notes Payable
IncreaseDecreaseInNotesPayable
9302000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
35000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1174000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3197000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
663000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11404000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1945000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-282000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
59000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4319000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-253000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5696000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30565000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2984000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4360000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
346000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
xpof Purchase Of Studios
PurchaseOfStudios
0
xpof Purchase Of Studios
PurchaseOfStudios
164000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1016000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1431000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
31000
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
393000
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
373000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
8500000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11761000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5613000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
38701000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
126100000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
41178000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1824000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
269000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
115000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1968000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2612000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8111000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
74000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0
xpof Payment For Tax Receivable Agreement
PaymentForTaxReceivableAgreement
136000
xpof Payment For Tax Receivable Agreement
PaymentForTaxReceivableAgreement
1163000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
130766000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
236000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
532000
xpof Payments For Proceeds From Contributions From Affiliates
PaymentsForProceedsFromContributionsFromAffiliates
0
xpof Payments For Proceeds From Contributions From Affiliates
PaymentsForProceedsFromContributionsFromAffiliates
-1290000
xpof Payments Of Shareholders Loan
PaymentsOfShareholdersLoan
0
xpof Payments Of Shareholders Loan
PaymentsOfShareholdersLoan
4400000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5012000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22133000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11077000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2819000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37094000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37370000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26017000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40189000
us-gaap Interest Paid Net
InterestPaidNet
20100000
us-gaap Interest Paid Net
InterestPaidNet
14958000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
407000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1102000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1179000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1265000
xpof Adjustment Of Preferred Stock To Redemption Value
AdjustmentOfPreferredStockToRedemptionValue
6094000
xpof Adjustment Of Preferred Stock To Redemption Value
AdjustmentOfPreferredStockToRedemptionValue
17109000
xpof Parent Contribution Of Rumble Assets
ParentContributionOfRumbleAssets
0
xpof Parent Contribution Of Rumble Assets
ParentContributionOfRumbleAssets
2250000
xpof Deemed Contribution From Redemption Of Convertible Preferred Stock
DeemedContributionFromRedemptionOfConvertiblePreferredStock
0
xpof Deemed Contribution From Redemption Of Convertible Preferred Stock
DeemedContributionFromRedemptionOfConvertiblePreferredStock
12679000
xpof Accrued Tax Withholdings Related To Convertible Preferred Stock Dividend
AccruedTaxWithholdingsRelatedToConvertiblePreferredStockDividend
0
xpof Accrued Tax Withholdings Related To Convertible Preferred Stock Dividend
AccruedTaxWithholdingsRelatedToConvertiblePreferredStockDividend
1316000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
446000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4059000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
275000
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0
us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
2150000
us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
0
us-gaap Nature Of Operations
NatureOfOperations
<p id="notes_to_consolidated_fs" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1 – Nature of Business and Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Xponential Fitness, Inc. (the “Company” or “XPO Inc.”), was formed as a Delaware corporation on January 14, 2020 for the purpose of facilitating an initial public offering (“IPO”) and entered into a series of transactions to implement an internal reorganization. Pursuant to a reorganization into a holding company structure, the Company is a holding company with its principal asset being an ownership interest in Xponential Fitness LLC (“XPO LLC”) through its ownership interest in Xponential Intermediate Holdings, LLC (“XPO Holdings”).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">XPO LLC was formed on August 11, 2017 as a Delaware limited liability company for the sole purpose of franchising fitness brands in several verticals within the boutique fitness industry. XPO LLC is a wholly owned subsidiary of XPO Holdings, which was formed on February 24, 2020, and prior to the IPO, ultimately, H&amp;W Franchise Holdings, LLC (the “Parent”). Prior to the formation of XPO Holdings, the Company was a wholly owned subsidiary of H&amp;W Franchise Intermediate Holdings, LLC (the “Member”).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company’s portfolio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">nine</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> brands consisted of: “Club Pilates,” a Pilates facility franchisor; “CycleBar,” a premier indoor cycling franchise; “StretchLab,” a fitness concept offering one-on-one assisted stretching services; “YogaSix,” a yoga concept that concentrates on connecting to one’s body in a way that is energizing; “AKT,” a dance-based cardio workout concept that combines toning, interval and circuit training; “Pure Barre,” a total body workout concept that uses the ballet barre to perform small isometric movements; “Rumble,” a boxing concept that offers boxing-inspired group fitness classes; “BFT,” a high-intensity interval training concept that combines functional, high-energy strength, cardio and conditioning-based classes, designed to achieve the unique health goals of its members; and “Lindora,” a provider of medically guided wellness and metabolic health solutions, which was acquired on January 2, 2024. The Company, through its boutique fitness brands, licenses its proprietary systems to franchisees who in turn operate studios to promote training and instruction programs to their club members within each vertical. Additionally, the Company, through its ownership of the Lindora brand, franchises clinics that provide medically guided wellness and metabolic health solutions to its members. In addition to franchised studios, the Company operated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">84</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> company-owned transition studios as of June 30, 2024 and 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 13, 2024, the Company divested the Stride brand, including the intellectual property, franchise rights and franchise agreements for open studios. On May 20, 2024, the Company divested the Row House brand, including the intellectual property, franchise rights and franchise agreements for open studios. See Note 3 for additional information.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the IPO, XPO Inc. entered into a series of transactions to implement an internal reorganization, (the “Reorganization Transactions”). The pre-IPO members of XPO Holdings (the “Pre-IPO LLC Members”) who retained their equity ownership in the form of limited liability company units (the “LLC Units”), immediately following the consummation of the Reorganization Transactions are referred to as “Continuing Pre-IPO LLC Members.”</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because XPO Inc. manages and operates the business and controls the strategic decisions and day-to-day operations of XPO LLC through its ownership of XPO Holdings and because it also has a substantial financial interest in XPO LLC through its ownership of XPO Holdings, it consolidates the financial results of XPO LLC and XPO Holdings, and a portion of its net income (loss) is allocated to the noncontrolling interest to reflect the entitlement of the Continuing Pre-IPO LLC Members to a portion of XPO Holdings’ net income or loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As the sole managing member of XPO LLC, the Company operates and controls all of the business and affairs of XPO LLC. The Company consolidates XPO LLC on its condensed consolidated financial statements and records a noncontrolling interest related to the Class B units held by the Class B stockholders on its condensed consolidated balance sheet and statement of operations.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basis of presentation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> – The Company’s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the Company has made all adjustments necessary to present fairly the condensed consolidated statements of operations, balance sheets, changes in stockholders' equity (deficit), and cash flows for the periods presented. Such adjustments are of a normal, recurring nature. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”). Interim results of operations are not necessarily indicative of results of operations to be expected for a full year.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On January 2, 2024, the Company acquired Lindora Franchise, LLC, a Delaware limited liability company, the franchisor of the Lindora wellness brand (the “Lindora Franchisor” or “Lindora”), and has included the results of operations of Lindora in its condensed consolidated statements of operations from the acquisition date forward. See Note 3 for additional information.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">–</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To conform with current year presentation, the Company has reclassified impairment charges of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7,238</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> from selling, general and administrative expenses to impairment of goodwill and other assets in the operating costs and expenses section of the condensed consolidated statements of operations for the three and six months ended June 30, 2023.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principles of consolidation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">–</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s consolidated financial statements include the accounts of its wholly owned subsidiaries. All intercompany transactions have been eliminated in consolidation.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> – The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements. Actual results could differ from these estimates under different assumptions or conditions.</span></p></div>
xpof Number Of Brands
NumberOfBrands
9
xpof Number Of Company Owned Studios
NumberOfCompanyOwnedStudios
1
xpof Number Of Company Owned Studios
NumberOfCompanyOwnedStudios
84
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">–</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To conform with current year presentation, the Company has reclassified impairment charges of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7,238</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> from selling, general and administrative expenses to impairment of goodwill and other assets in the operating costs and expenses section of the condensed consolidated statements of operations for the three and six months ended June 30, 2023.</span></p>
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
7238000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
7238000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> – The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements. Actual results could differ from these estimates under different assumptions or conditions.</span></p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2024Q2 us-gaap Revenues
Revenues
3502000
us-gaap Revenues
Revenues
6553000
CY2023Q2 us-gaap Revenues
Revenues
4007000
us-gaap Revenues
Revenues
6987000
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
11018000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
9333000
CY2024Q2 us-gaap Contract With Customer Asset Threshold Period Past Due
ContractWithCustomerAssetThresholdPeriodPastDue
P30D
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3319000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1467000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
947000
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3839000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1584000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
897000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
459000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2022000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3282000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3107000
CY2024Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2647000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2276000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2313000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
473000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8242000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5856000
CY2024Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
4230000
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
4798000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1957000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1564000
CY2024Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1139000
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1642000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2295000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1343000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4790000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4741000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14411000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14088000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6887000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9109000
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3467000
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3345000
CY2024Q2 xpof Tax Receivable Agreement Liability Current Portion
TaxReceivableAgreementLiabilityCurrentPortion
3686000
CY2023Q4 xpof Tax Receivable Agreement Liability Current Portion
TaxReceivableAgreementLiabilityCurrentPortion
2892000
CY2024Q2 xpof Other Current Liabilities
OtherCurrentLiabilities
6195000
CY2023Q4 xpof Other Current Liabilities
OtherCurrentLiabilities
4320000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20235000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
19666000
xpof Expected Duration Of Contracts
ExpectedDurationOfContracts
one year or less.
CY2023Q4 xpof Contract With Customer Liability Excluding Other Deferred Revenue
ContractWithCustomerLiabilityExcludingOtherDeferredRevenue
129702000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-14510000
xpof Changes In Deferred Revenue Due To Divestiture
ChangesInDeferredRevenueDueToDivestiture
-1258000
us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
8453000
CY2024Q2 xpof Contract With Customer Liability Excluding Other Deferred Revenue
ContractWithCustomerLiabilityExcludingOtherDeferredRevenue
122387000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5754000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10801000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11482000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12193000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12434000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
69723000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
122387000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
140575000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
151979000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111232000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
117305000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
29343000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
34674000
xpof Franchisee Agreement Term
FranchiseeAgreementTerm
P10Y
xpof Unsecured Advances Arrangement Term
UnsecuredAdvancesArrangementTerm
P18M
CY2024Q2 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
2760000
CY2023Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
3189000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18213000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15561000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18553000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19502000
CY2024Q2 us-gaap Depreciation
Depreciation
1590000
us-gaap Depreciation
Depreciation
3078000
CY2023Q2 us-gaap Depreciation
Depreciation
1403000
us-gaap Depreciation
Depreciation
2645000
CY2024Q2 us-gaap Goodwill
Goodwill
163036000
CY2023Q4 us-gaap Goodwill
Goodwill
171601000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
21024000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10113000
CY2024Q2 xpof Weighted Average Cost Of Capital Discount Rate
WeightedAverageCostOfCapitalDiscountRate
0.16
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
85760000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38135000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
47625000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86037000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38495000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
47542000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
158367000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38135000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120232000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
158644000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38495000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120149000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2927000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5875000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2885000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5840000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5698000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9880000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7477000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5955000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5750000
CY2024Q2 xpof Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
12865000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
47625000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
269000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
115000
CY2024Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
52000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
124000
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
14000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
297000
CY2024Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
363000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
218000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6137000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4279000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2573000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5147000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
322381000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
330101000
CY2024Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2023Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43387000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71413000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6887000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9109000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38047000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70141000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2174000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3177000
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
285000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
418000
CY2024Q2 us-gaap Lease Cost
LeaseCost
2459000
CY2023Q2 us-gaap Lease Cost
LeaseCost
3595000
us-gaap Operating Lease Cost
OperatingLeaseCost
5948000
us-gaap Operating Lease Cost
OperatingLeaseCost
5327000
us-gaap Variable Lease Cost
VariableLeaseCost
458000
us-gaap Variable Lease Cost
VariableLeaseCost
765000
us-gaap Lease Cost
LeaseCost
6406000
us-gaap Lease Cost
LeaseCost
6092000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1482000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2817000
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
50543000
us-gaap Operating Lease Payments
OperatingLeasePayments
3223000
us-gaap Operating Lease Payments
OperatingLeasePayments
4780000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
62164000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.102
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.084
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6601000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10349000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10417000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9844000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7734000
CY2024Q2 xpof Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
15347000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
60292000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15358000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
44934000
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
20000
xpof Additional Number Of Company Owned Studios
AdditionalNumberOfCompanyOwnedStudios
86
CY2023Q3 xpof Proceeds From Disgorgement Of Stockholders Short Swing Profits
ProceedsFromDisgorgementOfStockholdersShortSwingProfits
516000
CY2024Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
275000
us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
48250000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4196000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6055000
CY2024Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-136000
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
120000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4332000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5935000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8138000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12111000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
838000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
8138000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
11273000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
132000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000
CY2024Q2 xpof Pre Tax Book Income Loss Of Noncontrolling Interest
PreTaxBookIncomeLossOfNoncontrollingInterest
0.333
xpof Pre Tax Book Income Loss Of Noncontrolling Interest
PreTaxBookIncomeLossOfNoncontrollingInterest
0.333
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2023Q2 xpof Pre Tax Book Income Loss Of Noncontrolling Interest
PreTaxBookIncomeLossOfNoncontrollingInterest
0.333
xpof Pre Tax Book Income Loss Of Noncontrolling Interest
PreTaxBookIncomeLossOfNoncontrollingInterest
0.333
us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Company’s tax returns remain open for examination in the U.S. for years 2019 through 2023.
xpof Foreign Subsidiaries Tax Examination Period In Which Tax Obligation Originated
ForeignSubsidiariesTaxExaminationPeriodInWhichTaxObligationOriginated
P4Y
xpof Percentage Of Benefits Expected To Realize From Tax Benefits
PercentageOfBenefitsExpectedToRealizeFromTaxBenefits
0.15
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
1
CY2024Q2 xpof Deferred Tax Liability Recognized Tax Receivable Agreement Current
DeferredTaxLiabilityRecognizedTaxReceivableAgreementCurrent
3686000
CY2024Q2 xpof Deferred Tax Liability Recognized Tax Receivable Agreement Noncurrent
DeferredTaxLiabilityRecognizedTaxReceivableAgreementNoncurrent
780000
CY2024Q2 xpof Deferred Tax Liability Not Recognized Tax Receivable Agreement
DeferredTaxLiabilityNotRecognizedTaxReceivableAgreement
78182000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-13662000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
27524000
us-gaap Profit Loss
ProfitLoss
-18018000
us-gaap Profit Loss
ProfitLoss
12545000
CY2024Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-4607000
CY2023Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
23740000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-9546000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-849000
CY2024Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2150000
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1857000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4013000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3926000
CY2024Q2 xpof Deemed Contribution
DeemedContribution
2012000
CY2023Q2 xpof Deemed Contribution
DeemedContribution
45551000
xpof Deemed Contribution
DeemedContribution
-6094000
xpof Deemed Contribution
DeemedContribution
-17109000
xpof Deemed Contribution From Redemption Of Convertible Preferred Stock
DeemedContributionFromRedemptionOfConvertiblePreferredStock
12679000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9193000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
47478000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18579000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5038000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-849000
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1857000
CY2023Q2 xpof Deemed Dividend
DeemedDividend
45551000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9193000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3784000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18579000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4189000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31806000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33045000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31465000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31906000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31806000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41593000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31465000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50059000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
xpof Description Of Franchisees Requesting Settlement
DescriptionOfFranchiseesRequestingSettlement
On November 2, 2023, the Company received a letter from plaintiffs’ counsel purporting to represent unspecified current and former franchisees requesting settlement discussions. On July 31, 2024, plaintiffs’ counsel provided the Company with a list of approximately 250 current and former franchisees, certain of which current and former franchisees consist of more than one individual, that it purported to represent in this matter, who purport to have been aggrieved by alleged misstatements and omissions by the Company or an affiliate thereof. No litigation has been commenced, and the Company intends to vigorously defend itself in this matter. The Company recorded an accrual for estimated loss contingencies associated with this matter, which is included in accrued expenses in the condensed consolidated balance sheet. The accrual does not reflect the Company’s views of the merits of claims in this action.
CY2024Q2 xpof Letter Of Credit Accrued Potential Obligation
LetterOfCreditAccruedPotentialObligation
285000
CY2023Q4 xpof Letter Of Credit Accrued Potential Obligation
LetterOfCreditAccruedPotentialObligation
536000
CY2024Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
1365000
CY2023Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
2755000
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
2310000
us-gaap Restructuring Charges
RestructuringCharges
9244000
CY2024Q2 xpof Contract Termination And Other Associated Costs
ContractTerminationAndOtherAssociatedCosts
83000
xpof Contract Termination And Other Associated Costs
ContractTerminationAndOtherAssociatedCosts
605000
CY2024Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
421000
us-gaap Business Exit Costs1
BusinessExitCosts1
4617000
CY2024Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1806000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
4022000
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
2310000
us-gaap Restructuring Charges
RestructuringCharges
9244000
CY2024Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
421000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
4057000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
2182000
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
15969000
us-gaap Payments For Restructuring
PaymentsForRestructuring
11226000
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
6925000

Files In Submission

Name View Source Status
0000950170-24-090222-index-headers.html Edgar Link pending
0000950170-24-090222-index.html Edgar Link pending
0000950170-24-090222.txt Edgar Link pending
0000950170-24-090222-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xpof-20240630.htm Edgar Link pending
xpof-20240630.xsd Edgar Link pending
xpof-20240630_htm.xml Edgar Link completed
xpof-ex10_2.htm Edgar Link pending
xpof-ex31_1.htm Edgar Link pending
xpof-ex31_2.htm Edgar Link pending
xpof-ex32_1.htm Edgar Link pending
xpof-ex32_2.htm Edgar Link pending